CRC-SC with these markers depend on CHK1 activity, so LY2606368 treatment by inhibiting CHK1 impaired cell cycle checkpoint resulting in lethal replication catastrophe [145]. This evidence concerns the gene CHEK1 and colorectal carcinoma.